FM
FLXION MEDICAL, INC.
SEC filingBiotechnology · Magnolia, TX
Amount raised$21Ksold at filing
Total offeringNot stated
Investors in the raise1count reported to the SEC
FiledSep 9, 2025first sale Jul 6, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
James DoneganExecutive Officer, Director
Thor HalsethExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.